Clinical trial of high-dose oral medroxy
β
Enrique Davila; Charles L. Vogel; Dawn East; Victoria Cairns; Susan Hilsenbeck
π
Article
π
1988
π
John Wiley and Sons
π
English
β 696 KB
Recent studies have suggested that there are benefits from the use of high-dose parenteral medroxyprogesterone acetate (MPA) in the treatment of metastatic breast cancer. The present study was designed to assess the efficacy and toxicity of high-dose oral MPA in women with clinical parameters sugges